Tumor-suppressive miR-4732-3p is sorted into fucosylated exosome by hnRNPK to avoid the inhibition of lung cancer progression

Table 2 Relationship between the serum fucosylated exosomal miR-47323-3p levels and clinicopathological characteristics

Parameter	Number		Serum fucosylated exosomal miR-47323-3p		χ²	P-value
	Number	%	< Median	≥ Median	χ²	P-value
Age (years)
< 60	73	0.76	38	35	3.283	0.07
≥ 60	23	0.24	7	16
Gender
Male	70	0.73	46	24	3.033	0.082
Female	26	0.27	12	14
Type^a
LUAD	51	0.53	22	29	0.016	0.901
LUSC	43	0.45	18	25
Tumor invasion
T0-2	62	0.65	37	25	6.558	0.010^*
T3-4	34	0.35	11	23
Lymph node metastasis
N0	45	0.47	29	16	7.069	0.008^**
N1-3	51	0.53	19	32
M classification
M0	68	0.71	45	23	24.401	< 0.0001^****
M1	28	0.29	3	25
TNM Stage
0, I/II	65	0.68	44	21	25.201	< 0.0001^****
III/IV	31	0.32	4	27

^aTwo cases of large cell lung cancer were not included in the analysis of lung cancer subtype classification
^*p < 0.05
^**p < 0.01
^****p < 0.0001

ISSN: 1756-9966